1 mg tirzepatide Understand GLP-1/GIP Dual Agonist and Its Effect on Current Weight Loss Therapy GLP-Tirz (Oral) – Biostrategix

Ettinger, D

However, analysts noted the benefit was primarily driven by reductions in nonfatal myocardial infarctions, with no significant impact on cardiovascular death or stroke

This data is essential for a provider to determine if you are a candidate for a GLP-1 program

If you are ready to move forward, take the free assessment quiz to see which path is right for you

To view or add a comment, sign in More Relevant Posts Furosemide Class * Loop diuretic Mechanism of Action Furosemide inhibits the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, causing: * Increased excretion of sodium and water * Increased excretion of potassium, calcium, and magnesium * Rapid reduction of fluid overload Indications * Acute pulmonary edema * Congestive heart failure * Hypertension (especially with edema) * Chronic kidney disease with fluid overload * Nephrotic syndrome * Liver cirrhosis with edema * Hypercalcemia (with adequate hydration) Dosage Adults * Oral: 2080 mg daily, adjusted according to response * IV: 2040 mg initially